We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > hiPSC

News List

Neurophth Therapeutics and Hopstem Biotechnology Announce Strategic Partnership to Develop Human Induced Pluripotent Stem Cell-Derived Therapies for the Treatment of Ocular Diseases prnasia
June 02, 2021
Neurophth Biotechnology Ltd. announced a strategic partnership aiming to provide human iPSC-derived cell therapy for ocular diseases.
Toxys and Unilever Enter Agreement to Further Validate and Expand ReproTracker® for Animal-Free Developmental Toxicity Assessment b3cnewswire
May 25, 2021
Toxys and Unilever Safety and Environmental Assurance Centre (SEAC) have entered into an agreement to further validate and expand the ReproTracker assay.
Axxam and Fujifilm Cellular Dynamics Enter Alliance contractpharma
October 10, 2020
Axxam S.p.A. and Fujifilm Cellular Dynamics Inc. announced a strategic alliance to improve the drug discovery process.